# Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

> **NCT05669534** · PHASE4 · RECRUITING · sponsor: **University of Connecticut** · enrollment: 256 (estimated)

## Conditions studied

- Hiv
- Opioid Use Disorder

## Interventions

- **BEHAVIORAL:** community-friendly health recovery program
- **DRUG:** Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis

## Key facts

- **NCT ID:** NCT05669534
- **Lead sponsor:** University of Connecticut
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2025-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05669534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05669534, "Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05669534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*